[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] - Pradelli, Lorenzo; Ascierto, Paolo (Farmeconomia. Health economics and therapeutic pathways, 2017)